Kamlesh Khunti says a tirzepatide price rise pushed UK telehealth users to semaglutide
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Recap by typeshit. Post by Professor Kamlesh Khunti on X.